AMGN vs ELV
By Alex · Tickerpine
Amgen Inc. vs Elevance Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | ELV |
|---|---|---|
| Price | $358.33 | $395.18 |
| Market cap | $193.39B | $85.82B |
| P/E ratio | 24.9 | 16.8 |
| ROE | 101.32% | 12.09% |
| Profit margin | 20.96% | 2.62% |
| Revenue growth | 5.80% | 2.60% |
| Dividend yield | 2.81% | 1.74% |
| Beta | 0.42 | 0.68 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs ELV in plain English
- AMGN is the bigger company — about 2.3× the market cap of ELV.
- ELV is cheaper on earnings (P/E 16.8 vs 24.9).
- AMGN earns a higher return on equity (101% vs 12%).
- AMGN is growing revenue faster (6% vs 3%).
- AMGN has the higher dividend yield (2.81% vs 1.74%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
ELV return calculator
See what $1,000 in Elevance Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.